ARD BOARD

Meet the doctors on the board of ARD Foundation

Responsive image

DOCTOR ANTONIO BUZAID

Dr. Antonio C Buzaid graduated from the University of São Paulo, where he received the Rockefeller Foundation Award for Best Student in Basic Chairs. He completed a Fellowship in Hematology and Oncology at the University of Arizona where he was awarded the Eleanor B Connel Award for best fellowship. Shortly after, he was Assistant Professor at Yale University and Medical Director of the Melanoma Center and Co-Director of the Lung Cancer Center at this University for 4 years. He was then Associate Professor at MD Anderson Cancer Center and Medical Director of the Multidisciplinary Center for Melanoma and Skin Cancer for 5 years. At MDACC, he was awarded with the Teacher of the Year Award. In 1998 he created, together with Dr. Raul Cutait and Frederico Costa, the Oncology Center of the Syrian-Lebanese Hospital. From 1998 to 2010, he was Director of the Oncology Center of the Syrian-Lebanese Hospital. In 2011 he became General Medical Director of the Antonio Ermírio de Moraes Oncology Center of Portuguese Beneficence of São Paulo. In 2015, he became a Member of the Managing Committee of the Dayan-Daycoval Oncology Center of the Israeli Hospital Albert Einstein.
Responsive image

DOCTOR RENIER BRENTJENS

PhD in microbiology from SUNY Buffalo, Dr. Renier Brentjens is an associate member of the Memorial Sloan Kettering Cancer Center (MSKCC) and assistant physician for the leukemia service. He initiated preclinical studies demonstrating the potential clinical application of genetically modified T cells to target the CD19 antigen by retroviral transfer of genes from artificial T cell receptors, the famous chimeric antigen (CAR) receptors. Dr. Brentjens has successfully translated these studies into the clinical setting treating patients with chronic lymphocytic leukemia (CLL) and acute B-cell lymphoblastic leukemia (B-ALL). Pre-clinical research in progress is focused on the development of CAR-modified T cells designed to overcome the hostile immunosuppressive tumor microenvironment through the generation of "CAR armored T cells". The work in the Brentjens laboratory expanded this CAR technology to target additional tumor antigens expressed in other tumors, including the MUC-16 antigen target expressed in ovarian carcinomas, as well as the more ubiquitous WT-1 tumor associated antigen. These latter projects are also in the process of translating into the clinical environment.

Responsive image

DOCTOR RAFAELA QUEIROZ

Dr. Rafaela Queiroz Caixeta holds a degree in Medicine from the Faculty of Medical Sciences of Minas Gerais. Did Medical Residency in Ophthalmology at the Holy House of Mercy in Belo Horizonte eye Clinic by the CBO and AMB; Fellowship in Clinical and Surgical Retina at the Holy House of Mercy Eye Clinic in Belo Horizonte; Fellowship in Ocular Oncology, University of Cincinnati - Ohio / USA. She is currently a member of the Clinical Body of the Ophthalmology Excellence Nucleus in Belo Horizonte and is the preceptor of the medical residency of the Urgency and Retina department of the Holy House of Mercy Eye Clinic in Belo Horizonte. He also coordinates the Ocular Oncology (intraocular tumors) service of the Holy House of Mercy-BH Eye Clinic.
Responsive image

DOCTOR GEOPOLIANO CHAVES

Gepoliano Chaves obtained a bachelors degree in Biochemistry from the Federal University of Viçosa (MG) studying the effects of polyphenols on enzymes in the model of kidneys of mice with atherosclerosis (2012), and at the Biotechnology Laboratory of Dr. Nader Pourmand, UC Santa Cruz. Masters degree from the University of São Paulo, studying Plasmodium falciparum, the parasite that causes malaria. His interest in how proteins are detected in biological samples motivated interest in the Pourmand Laboratory. Gepoliano joined Pourmand Laboratory in 2014 in a project involving nanopipettes and next-generation sequencing. Since then, he has analyzed transcriptomic data in Huntingtons disease models, a neurodegenerative disorder. His dissertation work involves the use of nanopipettes to mitigate the nonspecific effects of the gene-editing technology by CRISPR / Cas9 and the underlying genetic analysis.

Responsive image

DOCTOR CLARISSA DE OLIVEIRA

Dr. Clarissa Aires de Oliveira is a physician from the Federal University of Uberlândia, specializing in Anesthesiology. She is an active member of the AMBB, a fellow in Clinical Nutrition from BARM, a postgraduate degree in nutritionology from the São Paulo Health School, a graduate in Nutrology from ABRAN, a member of Oncology Society from the Albert Einstein Hospital and a coordinator of the Specialization Course in Integrative Medicine of UNIUBE.
Responsive image

DOCTOR CLÁUDIA SOLMUCCI

Doctor hematologist, partner and owner of the Nucleus of Hematology/Oncology, coordinated for 22 years the Hematology service and the Blood Bank of the Biocor Hospital. Currently, Director-President of AbraC Brasil, Brazilian Association For Healing, association of research support.

Responsive image

DOCTOR CARLOS BARRIOS

Carlos Henrique Escosteguy Barrios holds a degree in Medicine from the Pontifical University of Rio Grande do Sul (1979). He is currently a professor at the Pontifical Catholic University of Rio Grande do Sul. He is the Director of the Cancer Hospital of the Mãe de Deus Health System. He is a physician at the São Lucas Hospital of PUCRS and director of the Latin American Clinical Research Group on Oncology (LACOG). he has a background in Internal Medicine, Hematology and Clinical Oncology, mainly in: Breast Cancer, Lung Cancer, Kidney Cancer and Clinical research. He has participated in over 200 Clinical Research projects and is particularly interested in the development of Clinical Research Cooperative structures in Latin America.
Responsive image

DOCTOR MARCOS SANTOS

Marcos Daniel de Deus Santos, doctor graduated from UFES in 1994, where he did Residency in Clinical Medicine in 1995 and 1996. He became a hematologist after residency at Hospital Felicio Rocho in Belo Horizonte/MG, in the period of 1997 and 1998. He completed his masters degree from UFMG in 2003 and since 2002 is a university professor, having lectured at the Faculty of Medical Sciences of MG, Emescam in Vitoria / ES, and since 2009, after passing a public examination, he became assistant professor of the Department of Clínica Médica, UFES, where he holds the chair of Hematology. He is Coordinator of Residence In Clinical Oncology and Coordinator of the Vila Velha Evangelical Hospital Hematology Department.